Epithalon — - 50mg

Epithalon, also known as Epitalon, is a synthetic tetrapeptide with the amino acid sequence Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly). It is the synthetic analogue of Epithalamin, a polypeptide extract derived from the pineal gland of bovine subjects. First identified and studied in the late 20th century, Epithalon has become a significant subject of investigation in the field of gerontology and cellular biology. Its primary notability stems from its reported ability to modulate fundamental biochemical processes associated with aging, most significantly the regulation of telomerase activity and the normalization of neuroendocrine functions.

The molecular structure of Epithalon is relatively simple, consisting of four amino acids, which contributes to its stability and potential for cellular interaction. Its molecular weight is approximately 390.35 g/mol. In laboratory settings, Epithalon is studied for its capacity to influence the pineal gland, which is central to regulating circadian rhythms through melatonin synthesis. Research suggests that by interacting with pineal functions, Epithalon may help restore cyclical hormonal release patterns that often become dysregulated with age, such as the balance between melatonin and cortisol.

This peptide is of particular interest to researchers investigating the mechanisms of cellular senescence. The 'Hayflick limit,' which describes the finite number of times a normal human cell population will divide before it stops, is directly linked to the progressive shortening of telomeres. Epithalon's proposed ability to activate the enzyme telomerase, which adds nucleotide repeats to the ends of chromosomes, makes it a valuable tool for studying how to counteract this fundamental aging process in vitro. Researchers utilizing Epithalon in their protocols are typically exploring its potential to extend cellular lifespan, improve physiological functions in animal models, and elucidate the complex interplay between the endocrine system and the cellular aging clock.

Nexa Peptides provides high-purity Epithalon (>99%) for laboratory and research use only. This product is not intended for human consumption or therapeutic application. It is a powerful tool for investigators seeking to understand the biochemical pathways governing longevity, cellular health, and the aging process at a molecular level. Each batch is rigorously tested to ensure identity and purity, providing researchers with a reliable reagent for their studies.

The primary mechanism of action investigated for Epithalon centers on its interaction with the genetic and endocrine systems, particularly its role in upregulating telomerase activity and modulating pineal gland function. The most extensively studied effect is its ability to induce the expression of the catalytic subunit of telomerase, known as hTERT (human Telomerase Reverse Transcriptase). In vitro studies in human cell cultures have demonstrated that Epithalon can bind to the promoter region of the hTERT gene. This interaction is believed to trigger a conformational change that facilitates the binding of transcription factors, thereby initiating the transcription of the gene and subsequent synthesis of the telomerase enzyme. By increasing the intracellular concentration of telomerase, Epithalon facilitates the elongation of telomeres, the protective nucleoprotein caps at the ends of chromosomes. This process counteracts the natural telomere shortening that occurs with each cycle of cell division, thus potentially extending the replicative lifespan of cells and delaying the onset of senescence in laboratory models.

Beyond its effects on telomeres, Epithalon's mechanism involves the regulation of the neuroendocrine system via the pineal gland. It is a synthetic version of Epithalamin, a natural pineal peptide mixture, and is proposed to mimic its biological activities. Research in animal models suggests that Epithalon can normalize the age-related decline in melatonin synthesis and release from the pineal gland. This restoration of a youthful melatonin secretion pattern helps re-establish healthy circadian rhythms. Proper circadian function is critical for regulating a cascade of downstream physiological processes, including the sleep-wake cycle, cortisol release patterns, and immune responses. By modulating the hypothalamic-pituitary-adrenal (HPA) axis, Epithalon has been shown in some preclinical studies to lower elevated cortisol levels, a common biomarker of stress and aging.

Furthermore, Epithalon exhibits antioxidant properties, although the precise molecular pathway is still under investigation. Some research indicates it may enhance the expression of endogenous antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPx), within cells. This action helps neutralize reactive oxygen species (ROS), reducing oxidative stress and cellular damage, which are key contributors to the aging process. The peptide's ability to reduce lipid peroxidation and protect cellular components from oxidative damage has been observed in various experimental models.

Lastly, some studies suggest Epithalon may influence gene expression beyond hTERT. Investigations using microarray analysis have indicated that it can modulate the expression of genes involved in protein synthesis, cellular metabolism, and immune function. For instance, in studies on aging rodents, administration of Epithalon was linked to the normalization of T-cell function and a restoration of thymic activity, suggesting a role in immunomodulation. The collective mechanisms—telomerase activation, neuroendocrine regulation, antioxidant activity, and gene expression modulation—make Epithalon a multifaceted compound for studying the molecular underpinnings of aging. All investigations into these pathways are confined to preclinical, in vitro, and in vivo laboratory research. This product is for Research Use Only.

Epithalon is a subject of intensive investigation across several domains of biomedical research, primarily focused on gerontology and the biology of aging. Its unique proposed mechanism of activating telomerase makes it a valuable tool for researchers studying cellular senescence. In vitro studies utilizing human fibroblast cell lines, for example, have explored Epithalon's capacity to overcome the Hayflick limit, demonstrating an extended replicative lifespan and a delayed onset of senescent morphology. These cell-based models allow researchers to dissect the molecular pathways by which telomere elongation impacts cellular health, gene expression, and resistance to apoptotic signals.

In preclinical animal models, typically rodents, research applications have expanded to systemic effects. Gerontological studies have investigated whether administration of Epithalon can ameliorate age-related physiological decline. These studies often measure biomarkers of aging, such as antioxidant enzyme activity, melatonin and cortisol levels, and immune function markers. For instance, researchers have explored its effects on restoring circadian rhythms in older animals, observing a normalization of nocturnal melatonin peaks. Such research aims to understand the link between the central 'pacemaker' in the pineal gland and the peripheral aging of various organ systems.

Immunological research represents another significant area of application. The age-associated decline of the immune system, or immunosenescence, is characterized by thymic involution and a reduction in T-cell function. Studies in aging mice have investigated Epithalon's potential to restore certain immunological parameters. Researchers have examined its effects on thymic structure, T-cell proliferation, and the overall functionality of the adaptive immune system in these models. These investigations provide insights into the interplay between the neuroendocrine system and immune regulation during aging.

Additionally, Epithalon has been studied in the context of metabolic and retinal health in animal models. Some research has explored its effects on glucose metabolism and insulin sensitivity in models of age-related metabolic syndrome. In the field of ophthalmology, preclinical studies using rodent models of retinitis pigmentosa have investigated Epithalon's potential to preserve retinal structure and function, possibly through its antioxidant and gene-regulatory effects. These diverse applications underscore the peptide's utility as a research compound for exploring fundamental aging processes across multiple biological systems. All uses of Epithalon are strictly for laboratory-based research and are not intended for any form of human or therapeutic use.